Pharmafile Logo

Equipping your medical affairs teams with solutions to navigate the healthcare landscape

February 26, 2020 |  

Dr Tyler Ray, OPEN Health Medical Communications

The healthcare landscape has experienced a significant transformation in the past two decades. The advancement in digital health technology, the availability of ‘big data’ and a focus on a value-for-patient economic environment are just some of the major contributing factors driving current trends.

The evolving changes in healthcare have highlighted the importance and relevance of medical affairs teams in the pharmaceutical and biotechnology industries. Medical affairs teams, with Medical Science Liaisons (MSLs) at their core, are now consistently recognised to be fundamental in companies’ strategies and value propositions. Traditionally, medical affairs teams and MSLs were often seen as a supporting function. However, given recent industry transformations and new requirements, medical affairs teams are now being described as the ‘third strategic pillar’ of a successful organisation and are increasingly considered to be equally as important as research and development (R&D) and commercial counterparts.1

The role of an MSL has progressively evolved since it was first established by the Upjohn Company in 1967.MSLs provide a crucial link between healthcare companies and healthcare decision makers, widely defined as physician, payer and patient. MSLs are a key resource within an organisation. They are central to providing scientific advice, training and insight generation, which is essential for overall company strategy development and implementation. External scientific engagement and exploration of mutual scientific and clinical interests by MSLs adds significant value to clinical practice, ultimately benefiting patients. MSLs Healthcare decision makers and providers are increasingly forming alliances with MSLs and medical affairs teams to help improve their understanding of the complex science and targeted medical treatments that are becoming widely available. These alliances are crucial for evidence- and value-based clinical decision making and deliver substantial benefits for research, healthcare education and patients.3

With such rapid changes in the industry and the increasing importance of medical affairs teams, what training programmes are needed to build a multifaceted and highly skilled team?

1 . A vision for medical affairs in 2025. https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/a-vision-for-medical-affairs-in-2025

2 . Morgan DK et al. History and evolution of field-based medical programs. Drug Inf J 2000;34:1049–1052.

3 . Doran E et al. Empirical uncertainty and moral contest: a qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia. Soc Sci Med 2006;62:1510–1519.

Pink divider

At OPEN Health Learning & Development, we step beyond traditional industry and medical affairs training programmes by developing your team’s knowledge, competencies and confidence.

We believe that medical affairs training programmes should have a focus on:

  1. Learner training needs developed from thorough analyses that are aligned to the specific requirements of medical affairs business units
  2. Enhancing a medical affairs team’s understanding of scientific content, stakeholder management principles and information management solutions
  3. Skills training that allows users to meet competencies that are tailored to the core medical affairs principals of communication, science, strategy and ethics

By combining the above, drawing on best practices in adult learning theory and leveraging technologies to achieve blended learning, programmes are designed with outcomes in mind to help clients maximise their teams’ potential and act as credible partners across the healthcare community.

Your teams are your most powerful tool; equipping them with the right resources will enhance their performance and maximise their potential, allowing you to set and implement smart and effective strategies for your business.

Pink divider

If you would like to know more about how OPEN Health Learning & Development can work in partnership with you to execute your internal training needs, please do get in touch.

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

Spotlight interview: 15 minutes on medical and scientific writing

Rob Pilbrow, Global Managing Director, Medical Writing, OPEN Health takes 15 minutes to answer some key questions on scientific writing

Spotlight interview: 15 minutes on healthcare advertising

Marie Little, Managing Director, OPEN Health Patient & Brand Communications takes 15 minutes to answer some key questions on healthcare advertising

Alexander Devine Website has gone live!

As part of the OPEN Health CSR programme one of the charities we support is Alexander Devine. They are a local Children's Hospice based in Maidenhead who provide a truly...

Spotlight interview: 15 minutes on patient-centricity in pharma

Sumira Riaz, Health Psychologist at OPEN Health Patient & Brand Communications, takes 15 minutes to answer some key questions on patient-centricity in pharma.

Spotlight interview: 15 minutes on patient engagement in pharma

Richard Jones, Managing Director Patient Engagement, OPEN Health Patient and Brand Communications, takes 15 minutes to answer some key questions on patient engagement in pharma

Rob Pilbrow joins OPEN Health as Global Managing Director, Medical Writing

OPEN Health Group have appointed Rob Pilbrow into the newly formed role of Global Managing Director, Medical Writing.

Spotlight interview: 15 minutes on the procurement function in pharma

Carwyn Jones, Senior Partner at OPEN Health, takes 15 minutes to answer some key questions on the procurement function in pharma.

Precision medicine with precision management and precision pricing; ensuring affordability in the cell and gene therapy era

The third plenary session at ISPOR in New Orleans focused on affordability in the face of new and expensive therapies and asked the question “is affordability driving a need to...

OPEN Health Medical Communications announces Group MD promotions and welcomes new Creative Director

OPEN Health Medical Communications has announced the promotion of two members of its senior leadership team. Jen van Zwieten and Margot Hannah become Group Managing Directors, with responsibility to oversee...

OPEN Health Graduates and the XP Support Group

During our graduate induction period in September 2018, we were asked to find a charity that could benefit from the expertise of the OPEN Health practices. We made the decision...